Article
Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer
29 Aug 2023
Abstract excerpt
Cytotoxic T lymphocyte-associated protein 4 (CTLA-4) is an immune checkpoint regulator exclusively expressed on T cells that obstructs the cell’s effector functions. Ipilimumab (Yervoy®), a CTLA-4 blocking antibody, emerged as a notable breakthrough in modern cancer treatment, showing upfront clinical benefits in multiple carcinomas. However, the exhilarating cost of checkpoint blockade therapy is discouraging...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
